Cuprina Holdings is trading 6.1% up at $2.42, with no clear company-specific catalyst reported for October 1. - The company sold 648,373 additional shares at $1.15, raising approximately $745,629; available reporting does not link the offering to today’s rise. - Cuprina is a biomedical and biotechnology company, not a crypto-focused business. Small gains in Bitcoin and Ethereum, alongside mixed index moves below 0.5%, do not clearly explain the stock’s move. - No volume data was provided.